ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,487,573 | -13.4% | 2,291,177 | +6.6% | 0.00% | -20.0% |
| Q2 2023 | $14,426,862 | -0.9% | 2,149,946 | +30.4% | 0.01% | 0.0% |
| Q1 2023 | $14,554,198 | +186731.8% | 1,648,361 | +61.6% | 0.01% | +150.0% |
| Q4 2022 | $7,790 | -99.8% | 1,019,739 | +49.7% | 0.00% | 0.0% |
| Q3 2022 | $4,848,000 | +44.2% | 681,077 | +63.9% | 0.00% | +100.0% |
| Q2 2022 | $3,361,000 | -47.7% | 415,484 | -10.2% | 0.00% | -50.0% |
| Q1 2022 | $6,425,000 | -51.7% | 462,924 | -2.4% | 0.00% | -50.0% |
| Q4 2021 | $13,315,000 | +86.9% | 474,508 | +126.4% | 0.00% | +100.0% |
| Q3 2021 | $7,124,000 | +38.3% | 209,606 | +66.3% | 0.00% | 0.0% |
| Q2 2021 | $5,151,000 | -4.9% | 126,057 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $5,414,000 | +9.3% | 134,492 | +60.5% | 0.00% | 0.0% |
| Q4 2020 | $4,955,000 | +644.0% | 83,791 | +511.6% | 0.00% | – |
| Q3 2020 | $666,000 | -54.4% | 13,700 | -54.6% | 0.00% | -100.0% |
| Q2 2020 | $1,461,000 | +55.9% | 30,206 | -10.4% | 0.00% | – |
| Q1 2020 | $937,000 | – | 33,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |